Perrigo Company plc Payments to Acquire Businesses, Gross
Perrigo Company plc (PRGO) reported Payments to Acquire Businesses, Gross of EUR 200.00 million for the 12-month period ending 2015-06-27, per its 10-K filed 2015-08-13.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesGross · last filed 2015-08-13
- Perrigo Company plc payments to acquire businesses, gross for fiscal 2015 was 200.00M EUR.
EUR
| Period end | Payments to Acquire Businesses, Gross 12 month |
|---|---|
| 2015-06-27 | 200.00M EUR 10-K · filed 2015-08-13 |
USD
| Period end | Payments to Acquire Businesses, Gross 12 month |
|---|---|
| 2015-06-27 | $223.40M 10-K · filed 2015-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |